Skip to main content
. 2021 Jun;17(2):210034. doi: 10.1183/20734735.0034-2021

Table 1.

Odds ratio of clinical features of severity in patients with heightened C-CS (C5 dose ≤2.44 µM)

OR (CI) p-value
Poor asthma control (ACT <20) 4.83 (1.97–10.4) 0.0004
Exacerbations ≥2 per year 2.83 (1.04–7.71) 0.04
Hospitalisations ≥1 per year 3.43 (0.91–12.9) 0.07